Letter: Urinary carcinoembryonic antigen to monitor exposure to urinary carcinogens.
D015081:2-Naphthylamine / Q000009:adverse effects; D002272:Carcinoembryonic Antigen / Q000652:urine*; D002617:Chemical Industry; D005260:Female; D006801:Humans; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000517:prevention & control / Q000652:urine*
D002272:Carcinoembryonic Antigen; D015081:2-Naphthylamine